POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement

Neurology

Volumn 63, Issue 7, 2004, Pages 1251-1257

  Van Goethem, G ^a,b,d   Luoma, P ^e   Rantamaki M ^f   Al Memar, A ^g   Kaakkola, S ^h   Hackman, P ^e   Krahe, R ⁱ   Lofgren A ^b,d   Martin, J J ^a,c   De Jonghe, P ^a,b,d   Suomalainen, A ^e   Udd, B ^e,j,k   Van Broeckhoven, C ^b,d  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e UNIVERSITY OF HELSINKI   (Finland)

^f SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^g ATKINSON MORLEY S HOSPITAL   (United Kingdom)

^h HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁱ UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^j VAASA CENTRAL HOSPITAL   (Finland)

^k TAMPERE UNIVERSITY HOSPITAL   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; DNA DIRECTED DNA POLYMERASE GAMMA; DNA POLYMERASE; DNA PRIMASE; MITOCHONDRIAL DNA; PROTEIN TWINKLE; UNCLASSIFIED DRUG; VALPROIC ACID;

ADULT; AMINO ACID SEQUENCE; ARTICLE; ATAXIA; AUTOPSY; BRAIN DISEASE; CARDIOMYOPATHY; CEREBELLUM DISEASE; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIGESTIVE SYSTEM FUNCTION DISORDER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSARTHRIA; ENZYME SUBUNIT; EPILEPSY; EXON; FAMILY; FEMALE; GASTROINTESTINAL MOTILITY; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LABORATORY TEST; LIVER TOXICITY; MALE; MOLECULAR GENETICS; MUSCLE MITOCHONDRION; MYOCLONUS; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; WEIGHT REDUCTION; WHITE MATTER;

EID: 20844442462     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000140494.58732.83     Document Type: Article

References (37)

1. Moraes CT, Shanske S, Tritschler HJ, et al. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 1991;48:492-501.
2. Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, DiDonato S. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 1989;339:309-311.
3. Yuzaki M, Ohkoshi N, Kanazawa I, Kagawa Y, Ohta S. Multiple deletions in mitochondrial DNA at direct repeats of non-D-loop regions in cases of familial mitochondrial myopathy. Biochem Biophys Res Commun 1989;164:1352-1357.
4. Cormier V, Rotig A, Tardieu M, Colonna M, Saudubray JM, Munnich A. Autosomal dominant deletions of the mitochondrial genome in a case of progressive encephalomyopathy. Am J Hum Genet 1991;48:643-648.
5. Ohno K, Tanaka M, Sahashi K, et al. Mitochondrial DNA deletions in inherited recurrent myoglobinuria. Ann Neurol 1991;29:364-369.
6. Suomalainen A, Paetau A, Leinonen H, Majander A, Peltonen L, Somer H. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 1992;340:1319-1320.
7. Bohlega S, Tanji K, Santorelli FM, Hirano M, al Jishi A, DiMauro S. Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 1996;46:1329-1334.
8. Blumenthal DT, Shanske S, Schochet SS, et al. Myoclonus epilepsy with ragged red fibers and multiple mtDNA deletions. Neurology 1998;50:524-525.
9. Paul R, Desnuelle C, Pouget J, et al. Importance of searching for associated mitochondrial DNA alterations in patients with multiple deletions. Eur J Hum Genet 2000;8:331-338.
10. Kaukonen J, Juselius JK, Tiranti V, et al. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 2000;289:782-785.
11. Spelbrink JN, Li FY, Tiranti V, et al. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 2001;28:223-231.
12. Van Goethem G, Dermaut B, Lofgren A, Martin JJ, Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 2001;28:211-212.
13. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999;283:689-692.
14. Hirano M, Silvestri G, Blake DM, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994;44:721-727.
15. Nishino I, Spinazzola A, Papadimitriou A, et al. Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol 2000;47:792-800.
16. Lamantea E, Tiranti V, Bordoni A, et al. Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann Neurol 2002;52:211-219.
17. Agostino A, Valletta L, Chinnery PF, et al. Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology 2003;60:1354-1356.
18. Di Fonzo A, Bordoni A, Crimi M, et al. POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions. Hum Mutat 2003;22:498-499.
19. Van Goethem G, Martin JJ, Dermaut B, et al. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 2003;13:133-142.
20. Rantamaki M, Krahe R, Paetau A, Cormand B, Mononen I, Udd B. Adult-onset autosomal recessive ataxia with thalamic lesions in a Finnish family. Neurology 2001;57:1043-1049.
21. Van Goethem G, Lofgren A, Dermaut B, Ceuterick C, Martin JJ, Van Broeckhoven C. Digenic progressive external ophthalmoplegia in a sporadic patient: recessive mutations in POLG and C10orf2/Twinkle. Hum Mutat 2003;22:175-176.
22. Alderborn A, Kristofferson A, Hammerling U. Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA sequencing. Genome Res 2000;10:1249-1258.
23. Suomalainen A, Majander A, Haltia M, et al. Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest 1992;90:61-66.
24. Kogelnik AM, Lott MT, Brown MD, Navathe SB, Wallace DC. MITO-MAP: a human mitochondrial genome database. Nucleic Acids Res 1996;24:177-179.
25. Cottrell DA, Ince PG, Blakely EL, et al. Neuropathological and histochemical changes in a multiple mitochondrial DNA deletion disorder. J Neuropathol Exp Neurol 2000;59:621-627.
26. Sparaco M, Bonilla E, DiMauro S, Powers JM. Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 1993;52:1-10.
27. Martin JJ. Thalamic degenerations. In: de Jong JMBV, ed. Handbook of Clinical Neurology, vol. 16/60, Hereditary Neuropathies and Spinocerebellar Atrophies. Amsterdam: Elsevier Science Publishers, 1991:701-715.
28. Van Goethem G, Schwartz M, Lofgren A, Dermaut B, Van Broeckhoven C, Vissing J. Novel POLG mutations in progressive external ophthalmoplegia mimicking mitochondrial neurogastrointestinal encephalomyopathy. Eur J Hum Genet 2003;11:547-549.
29. Van Goethem G, Mercelis R, Lofgren A, et al. Patient homozygous for a recessive POLG mutation presents with features of MERRF. Neurology 2003;61:1811-1813.
30. Van Goethem G, Martin JJ, Lofgren A, et al. Unusual presentation and clinical variability in Belgian pedigrees with progressive external ophthalmoplegia and multiple deletions of mitochondrial DNA. Eur J Neurol 1997;4:476-484.
31. Fadic R, Russell JA, Vedanarayanan VV, Lehar M, Kuncl RW, Johns DR. Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease. Neurology 1997;49:239-245.
32. Van Goethem G, Martin JJ, Van Broeckhoven C. Progressive external ophthalmoplegia characterized by multiple deletions of mitochondrial DNA: unraveling the pathogenesis of human mitochondrial DNA instability and the initiation of a genetic classification. Neuromolecular Med 2003;3:129-146.
33. Filosto M, Mancuso M, Nishigaki Y, et al. Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma. Arch Neurol 2003;60:1279-1284.
34. Moraes CT, Ricci E, Petruzzella V, et al. Molecular analysis of the muscle pathology associated with mitochondrial DNA deletions. Nat Genet 1992;1:359-367.
35. Ye F, Carrodeguas JA, Bogenhagen DF. The gamma subfamily of DNA polymerases: cloning of a developmentally regulated cDNA encoding Xenopus laevis mitochondrial DNA polymerase gamma. Nucleic Acids Res 1996;24:1481-1488.
36. Kaguni LS, Clayton DA. Template-directed pausing in in vitro DNA synthesis by DNA polymerase a from Drosophila melanogaster embryos. Proc Natl Acad Sci USA 1982;79:983-987.
37. Parton MJ, Broom W, Andersen PM, et al. D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype. Hum Mutat 2002;20:473.